Zogenix, Inc. Cancels IPO Published: Aug 05, 2008 Zogenix Inc., a San Diego-based drug company focused on pain management and CNS disorders, has withdrawn registration for an $86.25 million IPO, citing "general market conditions." Related links Private Equity Hub This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news